# Trump Includes Medical Cannabis Protections in 2026 Budget > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-protections-trump-budget-2026/ > **Published:** 2026-04-06T10:31:59-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:29:41-04:00 > **Clinical Summary:** Trump's 2026 budget includes medical cannabis protections, enhancing legal frameworks and patient access in states with medical cannabis programs. --- ✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyTHCSafety Clinical Summary The Trump administration has included medical cannabis protections in its proposed budget, a development that could strengthen the legal framework for patients and clinicians in states where cannabis is permitted for medical use. This budgetary action reflects ongoing federal recognition of medical cannabis as a distinct category deserving protection, potentially reducing regulatory uncertainty and improving access pathways for qualifying patients. The protection mechanisms outlined may facilitate interstate commerce of medical products, streamline banking and insurance processes for medical cannabis businesses, and clarify tax treatment under federal law, all of which have previously hindered clinical practice and patient access. For clinicians, such federal protections could enable more transparent documentation of cannabis recommendations and reduce liability concerns when recommending cannabis in states with established medical programs. Patients may experience improved consistency in product standards, clearer labeling, and reduced stigma associated with medical [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) when federal protections are enacted. Clinicians should monitor how these budget protections translate into specific regulatory guidance that affects their ability to counsel and document cannabis recommendations for appropriate patients. Dr. Caplan’s Take “What we’re seeing with these federal protections is finally an acknowledgment that patients deserve consistent access to a medicine we can actually study properly, and that means my patients in Louisiana aren’t penalized for what their neighbors in another state can freely use under their doctor’s care.” Clinical Perspective Recent federal budget actions that afford greater protections for medical cannabis represent a potential shift in the regulatory landscape, though clinicians should remain cautious about interpreting policy changes as endorsements of efficacy. The evidence base for cannabis in specific clinical contexts—such as chemotherapy-induced nausea, certain seizure disorders, and chronic pain—continues to evolve, but gaps remain regarding optimal dosing, long-term safety profiles, drug interactions, and patient selection criteria. Clinicians should be aware that enhanced legal protections do not necessarily resolve fundamental questions about quality control, standardization of products, or the distinction between medical-grade formulations and consumer market options. In practice, providers caring for patients interested in or currently using medical cannabis should maintain detailed documentation of therapeutic indication and response, remain vigilant about potential drug interactions (particularly with CYP3A4 and CYP2C19 substrates), and engage in shared decision-making that 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Trump+puts+medical+cannabis+protections+in+budget+%28Newsletter%3A+April+6%2C+2026%29+%40drcaplan&url=https%3A%2F%2Fwww.marijuanamoment.net%2Ftrump-puts-medical-cannabis-protections-in-budget-newsletter-april-6-2026%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.marijuanamoment.net%2Ftrump-puts-medical-cannabis-protections-in-budget-newsletter-april-6-2026%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Trump+puts+medical+cannabis+protections+in+budget+%28Newsletter%3A+April+6%2C+2026%29+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.marijuanamoment.net%2Ftrump-puts-medical-cannabis-protections-in-budget-newsletter-april-6-2026%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) - [CED Digest: 392 Items — March 11, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.marijuanamoment.net/trump-puts-medical-cannabis-protections-in-budget-newsletter-april-6-2026/](https://www.marijuanamoment.net/trump-puts-medical-cannabis-protections-in-budget-newsletter-april-6-2026/) Further Reading Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/real-time-long-term-effects-medical-marijuana-research/) Evidence Watch[Cannabis Use Is Associated With Increased Healthcare Utilization and Poorer Outcomes in Cyclical Vomiting Syndrome-A Propensity Matched Analysis of 34,988 Individuals.](https://cedclinic.com/cannabis-hyperemesis-syndrome-risk-cvs-healthcare-use/) Cannabis Policy WireUniversity of Washington et al.: Notice of Decision on Applicationfor Duty-Free Entry of Scientific Instruments [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Trump Reclassifies State-Licensed Medical Marijuana as a Less-Dangerous Drug in a Historic Shift](https://cedclinic.com/federal-medical-marijuana-reclassification-impact/) Explore the recent federal reclassification of state-licensed [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and its implications for patients and providers. [Read More](https://cedclinic.com/federal-medical-marijuana-reclassification-impact/) [Trump administration moves to ease restrictions on medical marijuana – NBC News](https://cedclinic.com/trump-administration-medical-marijuana-policy-update/) An overview of federal efforts to reduce barriers for medical marijuana access and regulation. [Learn More](https://cedclinic.com/trump-administration-medical-marijuana-policy-update/) [How Medical Marijuana Recommendations Expand Care](https://cedclinic.com/how-medical-marijuana-recommendations-expand-care/) Insights into how medical marijuana recommendations improve [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-review/) and clinical practice. [Discover More](https://cedclinic.com/how-medical-marijuana-recommendations-expand-care/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).